<didl:DIDL xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dip="urn:mpeg:mpeg21:2002:01-DIP-NS" xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xmlns:didl="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" DIDLDocumentId="https://arxiv.universalpublishings.com/id/eprint/96376" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd urn:mpeg:mpeg21:2005:01-DIP-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dip/dip.xsd">
  <didl:Item>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dii:Identifier>https://arxiv.universalpublishings.com/id/eprint/96376</dii:Identifier>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dcterms:modified>2026-06-19T05:23:37Z</dcterms:modified>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Component>
      <didl:Resource mimeType="application/xml" ref="https://arxiv.universalpublishings.com/cgi/export/eprint/96376/DIDL/arxiv-eprint-96376.xml"/>
    </didl:Component>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/descriptiveMetadata</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/xml">
          <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:relation>https://arxiv.universalpublishings.com/id/eprint/96376/</dc:relation>
        <dc:title>IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS</dc:title>
        <dc:creator>Kurbanova, Z.Ch</dc:creator>
        <dc:creator>Babadjanov, S.A</dc:creator>
        <dc:creator>Begmatova, U.A</dc:creator>
        <dc:description>Immune-mediated microvascular thrombosis (IMMT) is a complex disorder driven by immune dysregulation, leading to microvascular occlusion and necessitating anticoagulant therapy. This study evaluates the impact of anticoagulant therapy on hemostatic parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and inflammatory markers (C-reactive protein [CRP], interleukin-6 [IL-6]) in 45 patients with IMMT. Patients were followed for 12 months, receiving either warfarin or direct oral anticoagulants (DOACs). D-dimer levels decreased significantly (1.5 µg/mL to 0.6 µg/mL, p&amp;lt;0.01), with DOACs showing greater reduction (p=0.02). Fibrinogen remained elevated in 60% of patients (mean 4.3 ± 0.9 g/L), correlating with CRP (r=0.65, p&amp;lt;0.01). IL-6 levels declined from 12.5 pg/mL to 5.8 pg/mL (p&amp;lt;0.05), reflecting reduced inflammation. Thrombotic recurrence occurred in 18% of patients, associated with persistent fibrinogen elevation (OR 2.9, 95% CI 1.1–7.6, p=0.03). These findings highlight the role of hemostatic and inflammatory markers in monitoring therapy efficacy and predicting outcomes in IMMT, supporting personalized treatment approaches.</dc:description>
        <dc:date>2025-05-17</dc:date>
        <dc:type>Maqola</dc:type>
        <dc:type>NonPeerReviewed</dc:type>
        <dc:format>application/pdf</dc:format>
        <dc:language>en</dc:language>
        <dc:identifier>https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf</dc:identifier>
        <dc:identifier>  Kurbanova, Z.Ch, Babadjanov, S.A, Begmatova, U.A  (2025) IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS.  CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD, 2 (5).  pp. 137-142.      </dc:identifier>
        <dc:relation>https://universalconference.us/index.php/crismw/article/view/4428</dc:relation></oai_dc:dc>
        </didl:Resource>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/objectFile</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource ref="https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf" mimeType="application/pdf"/>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/humanStartPage</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/html" ref="https://arxiv.universalpublishings.com/id/eprint/96376/"/>
      </didl:Component>
    </didl:Item>
  </didl:Item>
</didl:DIDL>